Literature DB >> 14713334

The mammalian testis-specific thioredoxin system.

Antonio Miranda-Vizuete1, Christine M Sadek, Alberto Jiménez, William J Krause, Peter Sutovsky, Richard Oko.   

Abstract

Redox control of cell physiology is one of the most important regulatory mechanisms in all living organisms. The thioredoxin system, composed of thioredoxin and thioredoxin reductase, has emerged as a key player in cellular redox-mediated reactions. For many years, only one thioredoxin system had been described in higher organisms, ubiquitously expressed in the cytoplasm of eukaryotic cells. However, during the last decade, we and others have identified and characterized novel thioredoxin systems with unique properties, such as organelle-specific localization in mitochondria or endoplasmic reticulum, tissue-specific distribution mostly in the testis, and features novel for thioredoxins, such as microtubule-binding properties. In this review, we will focus on the mammalian testis-specific thioredoxin system that comprises three thioredoxins exclusively expressed in spermatids (named Sptrx-1, Sptrx-2, and Sptrx-3) and an additional thioredoxin highly expressed in testis, but also present in lung and other ciliated tissues (Txl-2). The implications of these findings in the context of male fertility and testicular cancer, as well as evolutionary aspects, will be discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14713334     DOI: 10.1089/152308604771978327

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  20 in total

Review 1.  As the world grows: contraception in the 21st century.

Authors:  R John Aitken; Mark A Baker; Gustavo F Doncel; Martin M Matzuk; Christine K Mauck; Michael J K Harper
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  Hydrogen peroxide modifies human sperm peroxiredoxins in a dose-dependent manner.

Authors:  Cristian O'Flaherty; Angela Rico de Souza
Journal:  Biol Reprod       Date:  2010-09-23       Impact factor: 4.285

3.  Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes.

Authors:  G J Pazour; N Agrin; B L Walker; G B Witman
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

Review 4.  Thioredoxin-related protein of 14 kDa as a modulator of redox signalling pathways.

Authors:  Belén Espinosa; Elias S J Arnér
Journal:  Br J Pharmacol       Date:  2018-10-06       Impact factor: 8.739

Review 5.  The mammalian Nm23/NDPK family: from metastasis control to cilia movement.

Authors:  Mathieu Boissan; Sandrine Dabernat; Evelyne Peuchant; Uwe Schlattner; Ioan Lascu; Marie-Lise Lacombe
Journal:  Mol Cell Biochem       Date:  2009-04-22       Impact factor: 3.396

6.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021

Review 7.  Redox reactions in mammalian spermatogenesis and the potential targets of reactive oxygen species under oxidative stress.

Authors:  Junichi Fujii; Hirotaka Imai
Journal:  Spermatogenesis       Date:  2014-12-31

8.  Organization and regulation of sex-specific thioredoxin encoding genes in the genus Drosophila.

Authors:  Malin J Svensson; Per Stenberg; Jan Larsson
Journal:  Dev Genes Evol       Date:  2007-08-14       Impact factor: 0.900

9.  A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia.

Authors:  Bénédicte Duriez; Philippe Duquesnoy; Estelle Escudier; Anne-Marie Bridoux; Denise Escalier; Isabelle Rayet; Elisabeth Marcos; Anne-Marie Vojtek; Jean-François Bercher; Serge Amselem
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 10.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.